PIRAS, DANIELA
PIRAS, DANIELA
100006 - Dipartimento di Farmacia
Abstract 2116:CHEK2(Chk2) endogenous activation is associated with p53 deficiency and downregulation ofBRCA2and Fanconi Anemia pathway gene members in the National Cancer Institute Anticancer Tumor Cell Line Panel (NCI-60)
2012-01-01 Zoppoli, Gabriele; Solier, Stéphanie; Reinhold, William C.; Liu, Hongfang; Connelly, John W.; Monks, Anne; Shoemaker, Robert H.; Abaan, Ogan D.; Davis, Sean R.; Piras, Daniela; Ballestrero, Alberto; Meltzer, Paul S.; Doroshow, James H.; Pommier, Yves
Dynamic simulations of pathways downstream of TGF-beta , Wnt and EGF-family growth factors, in colorectal cancer, including mutations and treatments with onco-protein inhibitors
2012-01-01 Tortolina, L.; Castagnino, N.; De Ambrosi, C.; Barla, A.; Verri, A.; Zoppoli, G.; Bagnasco, L.; Piras, D.; Patrone, F.; Ballestrero, A.
Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors.
2012-01-01 Bagnasco, Luca; Piras, Daniela; Parodi, Silvio; Bauer, Inga; Zoppoli, Gabriele; Patrone, Franco; Ballestrero, Alberto
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer
2016-01-01 Brown, David N.; Caffa, Irene; Cirmena, Gabriella; Piras, Daniela; Garuti, Anna; Gallo, Maurizio; Alberti, Saverio; Nencioni, Alessio; Ballestrero, Alberto; Zoppoli, Gabriele
Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial
2016-01-01 Castagnino, Nicoletta; Maffei, Massimo; Tortolina, Lorenzo; Zoppoli, Gabriele; Piras, Daniela; Nencioni, Alessio; Moran, Eva; Ballestrero, Alberto; Patrone, Franco; Parodi, Silvio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Abstract 2116:CHEK2(Chk2) endogenous activation is associated with p53 deficiency and downregulation ofBRCA2and Fanconi Anemia pathway gene members in the National Cancer Institute Anticancer Tumor Cell Line Panel (NCI-60) | 1-gen-2012 | Zoppoli, Gabriele; Solier, Stéphanie; Reinhold, William C.; Liu, Hongfang; Connelly, John W.; Monks, Anne; Shoemaker, Robert H.; Abaan, Ogan D.; Davis, Sean R.; Piras, Daniela; Ballestrero, Alberto; Meltzer, Paul S.; Doroshow, James H.; Pommier, Yves | |
| Dynamic simulations of pathways downstream of TGF-beta , Wnt and EGF-family growth factors, in colorectal cancer, including mutations and treatments with onco-protein inhibitors | 1-gen-2012 | Tortolina, L.; Castagnino, N.; De Ambrosi, C.; Barla, A.; Verri, A.; Zoppoli, G.; Bagnasco, L.; Piras, D.; Patrone, F.; Ballestrero, A. | |
| Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors. | 1-gen-2012 | Bagnasco, Luca; Piras, Daniela; Parodi, Silvio; Bauer, Inga; Zoppoli, Gabriele; Patrone, Franco; Ballestrero, Alberto | |
| Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer | 1-gen-2016 | Brown, David N.; Caffa, Irene; Cirmena, Gabriella; Piras, Daniela; Garuti, Anna; Gallo, Maurizio; Alberti, Saverio; Nencioni, Alessio; Ballestrero, Alberto; Zoppoli, Gabriele | |
| Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial | 1-gen-2016 | Castagnino, Nicoletta; Maffei, Massimo; Tortolina, Lorenzo; Zoppoli, Gabriele; Piras, Daniela; Nencioni, Alessio; Moran, Eva; Ballestrero, Alberto; Patrone, Franco; Parodi, Silvio |